Stock Screener App

Gratuito -

Installare

2.50

1.21% 0.03

Neumora Therapeutics Inc (NMRA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NMRA Giù? Forum Previsione

Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	6.77% 57.70	54.04	70.94	76.65	63.82
Operating Income/Loss	6.77% -57.70	-54.04	-70.94	-76.65	-63.82
Nonoperating Income/Loss	29.16% 0.945	1.334	3.049	4.152	5.247
Income/Loss From Continuing Operations Before Tax	7.68% -56.76	-52.71	-67.89	-72.49	-58.58
Income Tax Expense/Benefit	100.00% -	0.025	0.105	0.053	0.125
Income/Loss From Continuing Operations After Tax	7.63% -56.76	-52.73	-67.99	-72.55	-58.70
Net Income/Loss	7.63% -56.76	-52.73	-67.99	-72.55	-58.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.09% 161.84	161.69	161.45	159.58	158.98
Diluted Average Shares	0.09% 161.84	161.69	161.45	159.58	158.98
Basic Earnings Per Share	6.06% -0.35	-0.33	-0.42	-0.45	-0.37
Diluted Earnings Per Share	6.06% -0.35	-0.33	-0.42	-0.45	-0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters